MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,177M
Net Income
$198.3M
Net Profit Margin
9.11%
EPS
$1.03
Unit: Million (M) dollars
Revenue Breakdown
US
Others Countries
Revenue Breakdown
Knees
SET
Hips
Technology And Data Bone Cement ...
Revenue Breakdown
Americas
EMEA
Asia Pacific
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
2,177
2,086.7
2,243.7
2,001.4
Cost of products sold, excluding intangible asset amortization
635.5
576.2
792.4
559.3
Intangible asset amortization
163.4
162.1
177.8
176.5
Research and development
104.8
103.4
118.7
115.9
Selling, general and administrative
899.3
849.9
872.2
811.4
Restructuring and other cost reduction initiatives
29.8
6.3
106.3
21.4
Acquisition, integration, divestiture and related
18.1
15.6
21.8
-34.4
Operating expenses
1,850.9
1,713.5
2,089.2
1,650.1
Operating profit
326.1
373.2
154.5
351.3
Other income (expense), net
1.9
-3
15.4
3.3
Interest expense, net
-72.9
-68.8
-71.9
-75.4
Earnings before income taxes
255.1
301.3
98
279.2
Provision for income taxes
55.5
63
-40
48
Net earnings
199.6
238.3
137.9
231.2
Less net earnings attributable to noncontrolling interest
1.3
0.2
-1.6
0.3
Net earnings of zimmer biomet holdings, inc
198.3
238.1
139.4
230.9
Basic EPS
1.03
1.22
0.707
1.17
Diluted EPS
1.03
1.22
0.704
1.16
Basic Average Shares
192,200,000
195,000,000
197,100,000
198,100,000
Diluted Average Shares
192,800,000
195,800,000
198,000,000
198,800,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
US
$1,239.9M
(5.63%↑ Y/Y)
Others Countries
$937M
(3.71%↑ Y/Y)
Net sales
$2,177M
(4.80%↑ Y/Y)
Operating profit
$326.1M
(8.70%↑ Y/Y)
Other income
(expense), net
$1.9M
(-51.28%↓ Y/Y)
Operating expenses
$1,850.9M
(4.14%↑ Y/Y)
Earnings before income
taxes
$255.1M
(13.58%↑ Y/Y)
Interest expense, net
-$72.9M
(8.07%↑ Y/Y)
Selling, general and
administrative
$899.3M
(10.37%↑ Y/Y)
Cost of products
sold, excluding...
$635.5M
(7.31%↑ Y/Y)
Intangible asset
amortization
$163.4M
(1.74%↑ Y/Y)
Research and development
$104.8M
(-7.50%↓ Y/Y)
Restructuring and other cost
reduction initiatives
$29.8M
(70.29%↑ Y/Y)
Acquisition, integration,
divestiture and related
$18.1M
(-77.06%↓ Y/Y)
Net earnings
$199.6M
(30.12%↑ Y/Y)
Provision for income taxes
$55.5M
(-22.05%↓ Y/Y)
Net earnings of
zimmer biomet...
$198.3M
(29.78%↑ Y/Y)
Less net earnings
attributable to...
$1.3M
(116.67%↑ Y/Y)
Buy us a coffee
Zimmer_Biomet_logo-svg
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Zimmer_Biomet_logo-svg
ZIMMER BIOMET HOLDINGS, INC. (ZBH)